Plavix Label Revised To Include Prilosec Warning

Law360, New York (November 18, 2009, 5:16 PM EST) -- The U.S. Food and Drug Administration has announced labeling changes to Plavix, manufactured by Sanofi-Aventis SA and Bristol-Myers Squibb Co., to reflect new data showing that simultaneously taking the heartburn treatment Prilosec can sharply reduce the effects of the blockbuster blood thinner.

Taking proton pump inhibitors, a type of drug that includes Prilosec and Nexium, can block the effectiveness of the anti-clotting drug clopidogrel, co-marketed as Plavix, the FDA warned on Tuesday.

Clopidogrel, an anti-platelet that is used to prevent blood clots that could lead to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.